1. Chronic immunoneutralization of brain angiotensin-(1-12) lowers blood pressure in transgenic (mRen2)27 hypertensive rats.
- Author
-
Isa K, García-Espinosa MA, Arnold AC, Pirro NT, Tommasi EN, Ganten D, Chappell MC, Ferrario CM, and Diz DI
- Subjects
- Angiotensinogen, Angiotensins metabolism, Animals, Body Weight, Disease Models, Animal, Drinking, Eating, Hypertension genetics, Hypertension metabolism, Hypertension physiopathology, Infusion Pumps, Implantable, Male, Osmolar Concentration, Peptide Fragments metabolism, Rats, Rats, Transgenic, Renin genetics, Time Factors, Urodynamics, Angiotensins immunology, Blood Pressure, Brain metabolism, Hypertension prevention & control, Immunoglobulin G administration & dosage, Peptide Fragments immunology, Renin metabolism
- Abstract
Angiotensin-(1-12) [ANG-(1-12)] is a newly identified peptide detected in a variety of rat tissues, including the brain. To determine whether brain ANG-(1-12) participates in blood pressure regulation, we treated male adult (mRen2)27 hypertensive rats (24-28 wk of age) with Anti-ANG-(1-12) IgG or Preimmune IgG via an intracerebroventricular cannula for 14 days. Immunoneutralization of brain ANG-(1-12) lowered systolic blood pressure (-43 +/- 8 mmHg on day 3 and -26 +/- 7 mmHg on day 10 from baseline, P < 0.05). Water intake was lower on intracereroventricular day 6 in the Anti-ANG-(1-12) IgG group, accompanied by higher plasma osmolality on day 13, but there were no differences in urine volume, food intake, or body weight during the 2-wk treatment. In Preimmune IgG-treated animals, there were no significant changes in these variables over the 2-wk period. The antihypertensive effects produced by endogenous neutralization of brain ANG-(1-12) suggest that ANG-(1-12) is functionally active in brain pathways regulating blood pressure.
- Published
- 2009
- Full Text
- View/download PDF